Navigation Links
Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management
Date:12/12/2011

WITTEN, Germany, December 12, 2011 /PRNewswire/ --

Sangui enters commercialization phase / Initial order of Sangui developed wound spray

The Mexican State of Tamaulipas has issued an initial order of Hemo2Spray, the Sangui developed wound spray, as well as of the wound debridement product Scabremove both registered by the Mexican authorities in September this year. This is the first regular commercial order of the wound spray and Sangui management is positive that an era of innovative product development, testing and authorization will now come to fruition.

The medical product will initially be used in three state owned hospitals. While it will serve to treat patients suffering from chronic wounds its use in actual treatments will particularly be part of a comprehensive training program for doctors from other locations in Tamaulipas. The State health authorities have expressed their intent to apply the Sangui developed wound therapy in the 22 hospitals under their direction and start now in cooperation with Sangui medical staff to instruct and train their medical personnel. Global licensee SastoMed GmbH which is in charge of wound management operations expects that demand for the product will ramp up quickly when experienced doctors start treating patients throughout the state and as other Mexican states follow suit. Invoicing is to occur at short notice while shipment of the product is scheduled for early January 2012.

SanguiBioTech GmbH is a ninety percent owned subsidiary of Sangui BioTech International, Inc. (http://www.pinksheets.com: SGBI)

Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions.  Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information please contact:
Joachim Fleing
Phone: +49(160)741-27-17
Fax: +49(2302)915-191
e-mail: fleing@sangui.de



'/>"/>
SOURCE Sangui Bio Tech International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 Swine Flu Virus Outbreak
2. Biotechnology Company Provided Advance Warning of Mexican H1N1 "Swine Flu" Virus Outbreak
3. Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
4. CSL Behring Awards LEAD Grant to Patient Organizations to Educate Constituents on State Insurance Exchanges
5. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. Arizona State University engineers aim to improve performance of technology in extreme environments
8. Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
9. Chile Exports 14% of its Services to the United States and Operates as a Nearshore Center for the U.S.
10. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
11. Iowa State, Ames Lab physicist says nanoparticle assembly is like building with LEGOs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  HUYA Bioscience International, (HUYA), ... China,s pharmaceutical innovations, announced today a ... Innovation and Investment Company (referred to as CAS Innovation). ... innovations discovered by leading scientists at CAS to meet ... HUYA is the first company to have recognized ...
(Date:1/18/2017)... Research Future published a half-cooked research report on Global Cancer Diagnostics ... CAGR of 12% during the period 2016 to 2022. ... ... without any control. These abnormal cells have the ability to invade ... spread to other parts of the body through the blood and ...
(Date:1/17/2017)... The Global Implantable Biomaterials Market is ... 7.5% over the next decade to reach approximately ... trends that the market is witnessing include increasing ... transplant surgeries and medical implants and technological advancements. ... into immunomodulatory biomaterials, natural, polymers, hydrogels and ceramics. ...
(Date:1/17/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... and earnings conference call will be broadcast live over ... a.m. Eastern Time.  A news release detailing the quarterly ... a.m. Eastern Time the morning of the conference call. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology Technology:
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
(Date:12/7/2016)... December 7, 2016 BioCatch , the global ... its patent portfolio, which grew to over 40 granted and pending patents. ... , , ... patent entitled " System, Device, and Method Estimating Force Applied ... device makers to forego costly hardware components needed to estimate the force ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):